In March 2025, the company introduced new plans for a direct-to-consumer presenting of its Wegovy weight loss drug. The company founded a brand new pharmacy, identified as NovoCare, which might charge consumers $499 a month for use of the drug, fewer than 50 percent the expense of the drug through other pharmaceutical distribution networks.[fifty t